Improving Detection, Improving Outcomes in Cardiovascular Care

Prevalence of major depression among people with cardiovascular disease (CVD) is alarmingly high. Even more alarming is depression’s impact on cardiac prognosis. Recognizing the importance of the link between behavioral health and CVD, Polaris applies its collaborative behavioral care system to better detect, measure, monitor and address behavioral health conditions amongst cardiovascular patients.

Polaris synergizes state-of-the-art research and technology to help health care providers detect and monitor depression and anxiety in patients with heart disease, and improve the quality and cost-effectiveness of the services they offer.

Polaris’s CVD capabilities are grounded in extensive National Institutes of Health-sponsored research on treatment effectiveness and outcomes management, as well as medical studies of depression, anxiety and other critical CVD risk factors.

Patients whose treatment included assessment and monitoring using our technology experienced fewer heart attacks, strokes, nights in the hospital and emergency room visits than control subjects in a randomized clinical trial. Read about the trial.

Polaris answers these key questions for providers treating cardiovascular disease:

  • What behavioral health issues is my patient facing?
  • How can I lower the likelihood of subsequent cardiac events and hospital readmissions by better treating depression and anxiety?
  • Is my patient’s depression abnormally high compared to other cardiac patients?
  • Does my patient want a referral for medication or behavioral treatment for depression?
  • Has he/she had previous medical or behavioral treatment for depression? Did he/she feel that it was effective?